Salivary gland cancers: current treatments, molecular characteristics and new therapies (Q37134463)

18 August 2017

1 reference

title

Salivary gland cancers: current treatments, molecular characteristics and new therapies (English)

1 reference

18 August 2017

author name string

Sreenivasa R Chandana

series ordinal

1

1 reference

18 August 2017

Barbara A Conley

series ordinal

2

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Expert Review of Anticancer Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

645-652

1 reference

Major and minor salivary glands tumours

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Prognostic factors in head and neck mucoepidermoid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Systemic therapy in the palliative management of advanced salivary gland cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Gene expression profile of salivary adenoid cystic carcinoma associated with perineural invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

The epidermal growth factor receptor and its inhibition in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

c-erbB-2 Oncogene Expression in Salivary Gland Tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

HER2 expression in salivary gland carcinomas: dependence on histological subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

DNA analysis at p53 locus in adenoid cystic carcinoma: comparison of molecular study and p53 immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.645

21 January 2018

Identifiers

DOI

10.1586/14737140.8.4.645

1 reference

18 August 2017

1 reference